PAREXEL International (PRXL) Stock Price, News & Analysis

Company Overview

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries. Its segments include Clinical Research Services (CRS), PAREXEL Consulting Services (PC) and PAREXEL Informatics (PI). The CRS segment includes various phases of clinical research from first-in-man trials, where a medicinal entity is tested on human subjects for the first time, through post-marketing studies, following approval by the presiding regulatory body. The PC segment provides technical expertise and advice in areas, such as strategy, drug development, regulatory affairs, strategic compliance and targeted communications services in support of product launch. The Company's PI segment provides information technology solutions.

Key Stats

• Today's Range: $88.08 to $88.08
• 50-Day Range: $88.08 to $88.08
• 52-Week Range: $51.16 to $88.10
• Volume: N/A
• Average Volume: 1.04 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PRXL Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of PAREXEL International own?

Based on aggregate information from My MarketBeat watchlists, some other companies that PAREXEL International investors own include Bristol Myers Squibb (BMY), Meta Platforms (META), Icon (ICLR), Universal Display (OLED), Allergan (AGN), Baidu (BIDU) and Gilead Sciences (GILD).

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: NASDAQ:PRXL
• CIK: 799729
• Web: www.parexel.com
• Phone: +1-781-4879900
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A